What is CJC-1295 + Ipamorelin?
This research blend combines CJC-1295, a synthetic analog of growth hormone-releasing hormone (GHRH), with Ipamorelin, a selective growth hormone secretagogue and ghrelin-receptor agonist. It is supplied as a co-lyophilized powder for in-vitro laboratory research use only.
CJC-1295 + Ipamorelin research
Published work on these compounds is qualitative in the framing below. Each item describes the focus of the research itself, not an outcome for any person.
- GHRH-receptor signaling. Research has examined CJC-1295 activity at the GHRH receptor within in-vitro and animal models.
- Growth-hormone secretagogue signaling. Studies have investigated Ipamorelin at the ghrelin and growth-hormone-secretagogue receptor.
- Combined GHRH + secretagogue research. Investigations have explored the pairing of a GHRH analog with a secretagogue in research models.
- IGF-1 axis. Studies have examined growth-hormone and IGF-1 axis endpoints in research contexts.
CJC-1295 + Ipamorelin specifications
| CAS Number | CJC-1295: 863288-34-0 · Ipamorelin: 170851-70-4 |
|---|---|
| Synonyms | CJC-1295 (mod GRF 1-29), Ipamorelin |
| Molecular Formula | Provided on batch COA |
| Molecular Weight | Provided on batch COA |
| Sequence | Provided on batch COA |
| Purity | ≥99% by HPLC (each component) |
| Physical Form | Lyophilized powder |
| Solubility | Soluble in bacteriostatic or sterile water |
| Storage | Store lyophilized at -20°C; protect from light |
| Shelf Life | 24+ months lyophilized at -20°C |
| Presentation | 5 mg + 5 mg per vial |
CJC-1295 + Ipamorelin reconstitution & storage
Store the sealed lyophilized vial at -20°C. Reconstitute with bacteriostatic or sterile water by directing the stream against the vial wall; do not shake. After reconstitution, store refrigerated at 2 to 8°C and use within the period indicated on the batch COA. For laboratory research handling only.
CJC-1295 + Ipamorelin certificate of analysis (COA)
A batch-specific Certificate of Analysis accompanies every order. The COA documents identity and purity by HPLC for each component in the lot you receive, along with the molecular data listed as provided on batch COA above. Third-party analytical reports are available on request.
CJC-1295 + Ipamorelin research references
- Teichman SL, Neale A, Lawrence B, et al. Prolonged stimulation of growth hormone and IGF-I by CJC-1295. Journal of Clinical Endocrinology & Metabolism. 2006. PubMed
- Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology. 1998. PubMed
- PubChem records for CJC-1295 and Ipamorelin. PubChem
CJC-1295 + Ipamorelin FAQ
What is the CJC-1295 + Ipamorelin blend?
It is a research blend combining CJC-1295, a synthetic analog of growth hormone-releasing hormone (GHRH), with Ipamorelin, a selective growth hormone secretagogue and ghrelin-receptor agonist. It is supplied as a co-lyophilized powder for in-vitro laboratory research use only.
What purity does PeptideX1 meet for this blend?
Each component is ≥99% purity by HPLC, verified per batch on the accompanying Certificate of Analysis.
Is a Certificate of Analysis included?
Yes. A batch-specific Certificate of Analysis is included with every order.
How is it shipped and stored?
It ships lyophilized, sealed and desiccated. Store the sealed vial at -20°C and protect it from light.
Do CJC-1295 and ipamorelin affect growth hormone?
CJC-1295 (a GHRH analog) and ipamorelin (a selective growth-hormone secretagogue) have been studied for their combined effect on growth-hormone release in research models, and are sometimes discussed alongside HGH. This blend is supplied strictly as a research material and is not for human use.
Is this product for human use?
No. It is sold strictly for in-vitro laboratory research use only. It is not for human or veterinary use.